Talecris Biotherapeutics

  Home About Talecris Therapeutic Areas Research & Development Donor to Patient Business Development Investor Relations Media Center  
Media Center Overview
Press Releases
Press Releases Archive
News Features
The History of Talecris
Talecris Leadership
Talecris Media Contact Information

Press Releases


Subscribe to the Talecris Press Release RSS feed (W3C validated, Requires IE7 or higher)  

  December 17, 2009
Dean Mitchell Appointed to Talecris Board of Directors
 
  November 10, 2009
Talecris Biotherapeutics Announces Third Quarter 2009 Results
 
  October 30, 2009
Talecris Biotherapeutics to Report Third Quarter 2009 Financial Results
 
  October 21, 2009
Talecris Biotherapeutics Receives FDA Approval for PROLASTIN(R)-C
 
  October 16, 2009
Talecris Biotherapeutics Announces Pricing of $600 Million Senior Notes due 2016
 

 

 

Print This Page
E-mail This Page
News & Events
See how Talecris is being recognized for innovation and commitment.
Learn More

Talecris Biotherapeutics
Contact Talecris    Glossary    Site Map
General Conditions of Use    Privacy Statement    California Compliance
© 2009 Talecris Biotherapeutics